BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ActivBiotics 

128 Spring Street

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-372-4800 Fax: 781-274-9129


SEARCH JOBS


Industry
Pharmaceutical






 Company News
ActivBiotics Assignee Issues First Distribution of Cash to Creditors 6/20/2008 11:05:19 AM    More...
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million 4/3/2008 7:45:05 AM    More...
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million 4/2/2008 2:34:31 PM    More...
ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis of Cancer 3/6/2008 7:03:49 AM    More...
ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, on March 14, 2008 3/5/2008 7:44:35 AM    More...
ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 2/25/2008 8:13:36 AM    More...
ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superior to Azithromycin in the Treatment of Chlamydia STD 2/19/2008 6:58:33 AM    More...
ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2/5/2008 7:30:12 AM    More...
ActivBiotics Completes Sale of Fixed Assets 1/29/2008 7:07:39 AM    More...
ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Candidates 1/28/2008 2:58:47 PM    More...
1234

//-->